Merck Expands Access to New HIV Treatment IDVYNSO™ Through Agreement with the ADAP Crisis Task Force Merck, known as MSD outside the United States and Canada, has announced a new agreement with the ADAP Crisis Task Force (ACTF) aimed at…
Epicrispr Biotechnologies Reports Promising Phase 1/2 Data Showing Increased Muscle Volume with EPI-321 in Patients with Facioscapulohumeral Muscular Dystrophy Epicrispr Biotechnologies, a clinical-stage biotechnology company focused on developing epigenetic therapies, has announced encouraging interim results from its ongoing Phase 1/2…
MaaT Pharma to Seek EMA Re-Examination After CHMP Issues Negative Opinion on Conditional Marketing Application for Xervyteg® in Acute Graft-versus-Host Disease Clinical-stage biotechnology company MaaT Pharma has announced that the Committee for Medicinal Products for Human Use (CHMP) of the…
MRM Health Strengthens Board of Directors with Two Industry Veterans as Lead Microbiome Therapy Advances Toward Late-Stage Development MRM Health, a clinical-stage biotechnology company focused on developing microbiome-based therapeutics for immune-mediated diseases, has announced the appointment of two highly accomplished…
Carnegie Mellon-Led Team Secures Up to $39.3 Million ARPA-H Award to Develop OMEGA Fetal Monitoring System Carnegie Mellon University is spearheading a major multi-institution research initiative aimed at transforming how clinicians detect fetal distress during labor and delivery, after securing…
AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening, Early Detection and Survivorship Support Across the U.S. AstraZeneca and YMCA of the USA (Y-USA) have announced a new five-year partnership aimed at expanding cancer education, improving…
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that highlights the potential of advanced multi-microphysiological systems (multi-MPS) and computational…
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow cytometry workflows, a move designed to help laboratories increase throughput,…
Cynosure Lutronic’s XERF Surpasses 2,000 Installations Worldwide, Highlighting Growing Demand for Non-Invasive Skin Tightening Cynosure Lutronic has reached a new commercial milestone for XERF™, its multifrequency monopolar radiofrequency platform for non-invasive structural skin tightening, with the company announcing that the…
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on developing targeted genetic therapies for cancer and other serious diseases,…
Syntax Bio and Ajinomoto Health & Nutrition North America Partner to Evaluate StemFit™ Media for Next-Generation Cell Therapy Workflows Syntax Bio, a synthetic biology company focused on programming the next generation of cell therapies, has entered into a collaboration with…
Neuron23 Secures $2.5 Million Grant from The Michael J. Fox Foundation to Expand Precision Medicine Parkinson’s Trial into Israel Neuron23 Inc., a clinical-stage biotechnology company focused on advancing precision medicine approaches for Parkinson’s disease, has received a $2.5 million grant…